On Aug. 29, the Centers for Medicare & Medicaid Services (“CMS”) issued the inaugural list of drugs selected for price setting under the Inflation Reduction Act of 2022 (IRA).[1] Those selected drugs ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. These cuts, amounting to a net savings of $12 billion from last year's ...
These drugs represent the top 10 “qualifying single source” drugs with the highest expenditures under the Medicare Part D program. “Qualifying drugs” include small molecule drug products that were ...
The Centers for Medicare and Medicaid Services is testing three models to lower the price of drugs, including having a $2 Medicare drug list for about 150 low-cost generics. The Medicare $2 Drug List ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results